Oral vinorelbin in combination with cisplatin or carboplatin in adjutant chemotherapy of non-snall lung cancer: A prospective study of feasibility, tolerabity an 3-year surfoval

Autoři	KOLEK Vítězslav GRYGÁRKOVÁ Ivona CHALUPA Jiří KOUBKOVÁ Leona ŠVECOVÁ Jiřina SKŘIČKOVÁ Jana OSTŘÍŽKOVÁ Lenka SIXTOVÁ Dimka
Rok publikování	2011
Druh	Konferenční abstrakty
Fakulta / Pracoviště MU	Lékařská fakulta
Citace
Popis	Adjuvant cisplatinum-based chemotherapy is recommended for routine use in patients with stages IIA, IIB, and IIIA of non smallcell lung cancer (NSCLC) after radical resection. Results in stage IB were not conclusive. Vinorelbine is a preferable associated drug in this indication and a randomized study proved the comparable effectiveness and tolerability of vinorelbine given both orally or intravenously (i.v.) in advanced NSCLC, meanwhile oral vinorelbine gives better comfort to patients.